Measures for Improved Availability of medicines and vaccines (MIA)
Ensuring availability of essential medicines, vaccines and health commodities is one of today’s critical societal challenges
2022
-
Pettersen, M.S. and Wangen, A.K.
Perceptions of non-price criteria in pharmaceutical tenders
BI Norwegian Business School.
-
Julsvoll, A.A. and Sickenberger, M.
How can Blockchain Technology be used to support Supply Chain Risk Management in Drug Supply Chains?
BI Norwegian Business School
-
Sun, J.
The feasibility of medication reuse programs implementation: a multiple case study
Rotterdam School of Management, Erasmus University.
-
Ngoc, A.
What are the effects of reshoring the active pharmaceutical ingredient (API) manufacturing on the medicine availability in Europe?
Rotterdam School of Management, Erasmus University.
-
Moolenaar, D.
Examining safety stock policies for pharmaceuticals
Rotterdam School of Management, Erasmus University.
-
Moolenaar, D.
The relationship between price policies and drug shortages in The Netherlands
Rotterdam School of Management, Erasmus University.
-
Hiort, R.
Drug Shortages in Europe: Investigation of the Relationship between Drug Prices and Shortages of Drugs in European Countries
Rotterdam School of Management, Erasmus University
2021
-
Moe, A. F. and Wright, H.
Availability of antibiotics in Norway
BI Norwegian Business School
-
Bruijnooge, L.
The effect of tendering on the availability of generic medicines in the Netherlands
Rotterdam School of Management, Erasmus University
-
Van Heeswijk, T.
What are the Main Drivers for Medicine Shortages in Belgium, A Data Driven Approach
Rotterdam School of Management, Erasmus University
-
Van Staveren, L.
The Dutch Iron Stock Policy
Rotterdam School of Management, Erasmus University.
-
Praveen, M.
Immunization supply chain of India (A Case study on challenges for COVID-19 vaccination
Lund University
-
Olivier, M.
The Medicine Sourcing Problem compared across European Countries
Rotterdam School of Management, Erasmus University.
-
Ly, S.
“Iron Stock” policies for medicines in the Netherlands
Rotterdam School of Management, Erasmus University.
-
Bastholm, H. and Trau, Shan
PPE preparedness in Norwegian public hospitals. A case study of COVID-19
BI Norwegian Business School
-
Arron, K
Procurement and supply of drugs in the English NHS: A review and analysis of tendering and contracting practices in secondary care
Department of Management Science, Lancaster University Management School.
-
Joele, F.
End-to-end supply chain visibility in the pharmaceutical industry
Rotterdam School of Management, Erasmus University
2020
-
Li, Q.
Understanding supply chain resilience from an equifinality perspective: Lessons from governments’ responses to ventilator shortages during the COVID-19 outbreak
Lancaster University